These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38801034)

  • 21. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
    Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
    West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of a rural emergency department-initiated buprenorphine program in the mountain west: a study protocol.
    Seliski N; Madsen T; Eley S; Colosimo J; Engar T; Gordon A; Barnett C; Humiston G; Morsillo T; Stolebarger L; Smid MC; Cochran G
    Addict Sci Clin Pract; 2024 Sep; 19(1):63. PubMed ID: 39228007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A qualitative assessment of emergency physicians' experiences with robust emergency department buprenorphine bridge programs.
    Heil JM; Lassiter JM; Salzman MS; Herring A; Hoppe J; Lynch M; Weiner SG; Roberts B; Haroz R
    Acad Emerg Med; 2024 Jun; 31(6):576-583. PubMed ID: 38357749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey.
    Lowenstein M; Kilaru A; Perrone J; Hemmons J; Abdel-Rahman D; Meisel ZF; Delgado MK
    Am J Emerg Med; 2019 Sep; 37(9):1787-1790. PubMed ID: 30803850
    [No Abstract]   [Full Text] [Related]  

  • 25. Nudging Emergency Department-Initiated Addiction Treatment.
    Butler K; Chavez T; Wakeman S; Robertson T; Leifer J; Barofsky J; Kao LS; Lefkowitz J; Dutta S; Hayes B; White B; Raja A; Martin A
    J Addict Med; 2022 Jul-Aug 01; 16(4):e234-e239. PubMed ID: 34775439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing.
    Foster SD; Lee K; Edwards C; Pelullo AP; Khatri UG; Lowenstein M; Perrone J
    Ann Emerg Med; 2020 Aug; 76(2):206-214. PubMed ID: 32376089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
    Andrilla CHA; Moore TE; Patterson DG
    J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians.
    MacKinnon N; Lane D; Scheuermeyer F; Kaczorowski J; Dong K; Orkin AM; Daoust R; Moe J; Andolfatto G; Klaiman M; Yan J; Koh JJ; Crowder K; Atkinson P; Savage D; Stempien J; Besserer F; Wale J; Kestler A
    PLoS One; 2024; 19(2):e0297084. PubMed ID: 38315732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
    Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
    JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.
    Burke KN; Krawczyk N; Li Y; Byrne L; Desai IK; Bandara S; Feder KA
    J Subst Use Addict Treat; 2024 Jul; 162():209351. PubMed ID: 38499248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study.
    Heil J; Ganetsky VS; Salzman MS; Hunter K; Baston KE; Carroll G; Ketcham E; Haroz R
    West J Emerg Med; 2022 Apr; 23(3):386-395. PubMed ID: 35679506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Resident Physicians' Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder.
    Shuey B; Lee D; Ugalde I; Borgan S; Bresnan C; Qureshi M; Mhaskar R; Oxner A
    J Addict Med; 2021 May-Jun 01; 15(3):219-225. PubMed ID: 33079729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in opioid use disorder clinical presentations and treatment in the emergency department: A mixed-methods study.
    Faude S; Delgado MK; Perrone J; McFadden R; Xiong RA; O'Donnell N; Wood C; Solomon G; Lowenstein M
    Am J Emerg Med; 2023 Apr; 66():53-60. PubMed ID: 36706482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional survey on buprenorphine-naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey.
    Kestler A; Kaczorowski J; Dong K; Orkin AM; Daoust R; Moe J; Van Pelt K; Andolfatto G; Klaiman M; Yan J; Koh JJ; Crowder K; Webster D; Atkinson P; Savage D; Stempien J; Besserer F; Wale J; Lam A; Scheueremeyer F
    CMAJ Open; 2021; 9(3):E864-E873. PubMed ID: 34548331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
    Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
    BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to primary care physicians prescribing buprenorphine.
    Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA
    Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why aren't physicians prescribing more buprenorphine?
    Huhn AS; Dunn KE
    J Subst Abuse Treat; 2017 Jul; 78():1-7. PubMed ID: 28554597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial.
    Melnick ER; Jeffery MM; Dziura JD; Mao JA; Hess EP; Platts-Mills TF; Solad Y; Paek H; Martel S; Patel MD; Bankowski L; Lu C; Brandt C; D'Onofrio G
    BMJ Open; 2019 May; 9(5):e028488. PubMed ID: 31152039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.